BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 34152739)

  • 1. Cryptic Sites in Tau Fibrils Explain the Preferential Binding of the AV-1451 PET Tracer toward Alzheimer's Tauopathy.
    Murugan NA; Nordberg A; Ågren H
    ACS Chem Neurosci; 2021 Jul; 12(13):2437-2447. PubMed ID: 34152739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting the Binding Profile of PET Tracers to Corticobasal Degeneration Tau Fibrils.
    Zhou Y; Li J; Nordberg A; Ågren H
    ACS Chem Neurosci; 2021 Sep; 12(18):3487-3496. PubMed ID: 34464084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies.
    Ono M; Sahara N; Kumata K; Ji B; Ni R; Koga S; Dickson DW; Trojanowski JQ; Lee VM; Yoshida M; Hozumi I; Yoshiyama Y; van Swieten JC; Nordberg A; Suhara T; Zhang MR; Higuchi M
    Brain; 2017 Mar; 140(3):764-780. PubMed ID: 28087578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational Insight into the Binding Profile of the Second-Generation PET Tracer PI2620 with Tau Fibrils.
    Kuang G; Murugan NA; Zhou Y; Nordberg A; Ågren H
    ACS Chem Neurosci; 2020 Mar; 11(6):900-908. PubMed ID: 32069017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [
    Marquié M; Agüero C; Amaral AC; Villarejo-Galende A; Ramanan P; Chong MST; Sáez-Calveras N; Bennett RE; Verwer EE; Kim SJW; Dhaynaut M; Alvarez VE; Johnson KA; McKee AC; Frosch MP; Gómez-Isla T
    Acta Neuropathol Commun; 2019 Oct; 7(1):164. PubMed ID: 31661038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different Positron Emission Tomography Tau Tracers Bind to Multiple Binding Sites on the Tau Fibril: Insight from Computational Modeling.
    Murugan NA; Nordberg A; Ågren H
    ACS Chem Neurosci; 2018 Jul; 9(7):1757-1767. PubMed ID: 29630333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Simulations Reveal Distinct Energetic and Kinetic Binding Properties of [
    Künze G; Kümpfel R; Rullmann M; Barthel H; Brendel M; Patt M; Sabri O
    ACS Chem Neurosci; 2022 Jul; 13(14):2222-2234. PubMed ID: 35762647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pick's Tau Fibril Shows Multiple Distinct PET Probe Binding Sites: Insights from Computational Modelling.
    Mishra SK; Yamaguchi Y; Higuchi M; Sahara N
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An autoradiographic evaluation of AV-1451 Tau PET in dementia.
    Lowe VJ; Curran G; Fang P; Liesinger AM; Josephs KA; Parisi JE; Kantarci K; Boeve BF; Pandey MK; Bruinsma T; Knopman DS; Jones DT; Petrucelli L; Cook CN; Graff-Radford NR; Dickson DW; Petersen RC; Jack CR; Murray ME
    Acta Neuropathol Commun; 2016 Jun; 4(1):58. PubMed ID: 27296779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [
    Lagarde J; Olivieri P; Caillé F; Gervais P; Baron JC; Bottlaender M; Sarazin M
    J Neurol; 2019 Dec; 266(12):3087-3097. PubMed ID: 31535269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and preclinical characterization of [
    Kroth H; Oden F; Molette J; Schieferstein H; Capotosti F; Mueller A; Berndt M; Schmitt-Willich H; Darmency V; Gabellieri E; Boudou C; Juergens T; Varisco Y; Vokali E; Hickman DT; Tamagnan G; Pfeifer A; Dinkelborg L; Muhs A; Stephens A
    Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2178-2189. PubMed ID: 31264169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of tau positron emission tomography tracer [
    Sander K; Lashley T; Gami P; Gendron T; Lythgoe MF; Rohrer JD; Schott JM; Revesz T; Fox NC; Årstad E
    Alzheimers Dement; 2016 Nov; 12(11):1116-1124. PubMed ID: 26892233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assembly of recombinant tau into filaments identical to those of Alzheimer's disease and chronic traumatic encephalopathy.
    Lövestam S; Koh FA; van Knippenberg B; Kotecha A; Murzin AG; Goedert M; Scheres SHW
    Elife; 2022 Mar; 11():. PubMed ID: 35244536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evaluation of [
    Varlow C; Mathis CA; Vasdev N
    Nucl Med Biol; 2024; 130-131():108891. PubMed ID: 38458074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies.
    Marquié M; Normandin MD; Meltzer AC; Siao Tick Chong M; Andrea NV; Antón-Fernández A; Klunk WE; Mathis CA; Ikonomovic MD; Debnath M; Bien EA; Vanderburg CR; Costantino I; Makaretz S; DeVos SL; Oakley DH; Gomperts SN; Growdon JH; Domoto-Reilly K; Lucente D; Dickerson BC; Frosch MP; Hyman BT; Johnson KA; Gómez-Isla T
    Ann Neurol; 2017 Jan; 81(1):117-128. PubMed ID: 27997036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue.
    Marquié M; Normandin MD; Vanderburg CR; Costantino IM; Bien EA; Rycyna LG; Klunk WE; Mathis CA; Ikonomovic MD; Debnath ML; Vasdev N; Dickerson BC; Gomperts SN; Growdon JH; Johnson KA; Frosch MP; Hyman BT; Gómez-Isla T
    Ann Neurol; 2015 Nov; 78(5):787-800. PubMed ID: 26344059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-interaction of tau PET tracers with monoamine oxidase B: evidence from in silico modelling and in vivo imaging.
    Murugan NA; Chiotis K; Rodriguez-Vieitez E; Lemoine L; Ågren H; Nordberg A
    Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1369-1382. PubMed ID: 30919054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tau positron-emission tomography tracer AV-1451 binds with similar affinities to tau fibrils and monoamine oxidases.
    Vermeiren C; Motte P; Viot D; Mairet-Coello G; Courade JP; Citron M; Mercier J; Hannestad J; Gillard M
    Mov Disord; 2018 Feb; 33(2):273-281. PubMed ID: 29278274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insight into the Binding of First- and Second-Generation PET Tracers to 4R and 3R/4R Tau Protofibrils.
    Li J; Kumar A; Långström B; Nordberg A; Ågren H
    ACS Chem Neurosci; 2023 Sep; 14(18):3528-3539. PubMed ID: 37639522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Contrast In Vivo Imaging of Tau Pathologies in Alzheimer's and Non-Alzheimer's Disease Tauopathies.
    Tagai K; Ono M; Kubota M; Kitamura S; Takahata K; Seki C; Takado Y; Shinotoh H; Sano Y; Yamamoto Y; Matsuoka K; Takuwa H; Shimojo M; Takahashi M; Kawamura K; Kikuchi T; Okada M; Akiyama H; Suzuki H; Onaya M; Takeda T; Arai K; Arai N; Araki N; Saito Y; Trojanowski JQ; Lee VMY; Mishra SK; Yamaguchi Y; Kimura Y; Ichise M; Tomita Y; Zhang MR; Suhara T; Shigeta M; Sahara N; Higuchi M; Shimada H
    Neuron; 2021 Jan; 109(1):42-58.e8. PubMed ID: 33125873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.